Stocks and Investing Stocks and Investing
Thu, April 30, 2020

Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $88 on, Apr 30th, 2020


Published on 2024-10-27 04:41:49 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $103 to $88 on, Apr 30th, 2020.

Andrew has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $66 on, Wednesday, April 29th, 2020
  • George Farmer of "BMO Capital" Maintained at Buy with Decreased Target to $75 on, Wednesday, April 29th, 2020
  • Konstantinos Aprilakis of "JMP Securities" Maintained at Buy with Decreased Target to $103 on, Wednesday, April 29th, 2020
Contributing Sources